Efficacy of homoeopathic treatment for Diabetic Distal Symmetric Polyneuropathy: A multicentric randomized double blind placebo controlled clinical trial

Central Council for Research in Homoeopathy0 个研究点目标入组 84 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Both sexes of age between 30-70 years.
•Diagnosed cases of Type 2 Diabetes stable with allopathic treatment for last 3 months.
•Abnormal Nerve conduction test.
•HbA1C <= 8%.
•Controlled Hypertension
•Written Informed consent from the patient.

•i.Diabetic Mononeuropathy
•ii.Diabetic Polyradiculopathy
•iii.Diabetic amyotrophy
•iv.Diabetic Autonomic Neuropathy
•v.Abnormalities of gait
•vi.Development of typical Charcotâ??s joints, particularly in the feet
•vii.Loss of arch with multiple fractures of tarsal bones
•viii.Wrist drop
•ix.Foot drop
•x.Paralysis of III, IV or VI Cranial Nerves
•xi.Myocardial infarction less than 6 months
•xii.Unstable angina
•xiii.Neuropathy due to other causes e.g. Vitamin B12 deficiency.
•xiv.Alcohol addiction or dependence
•xv.Cases presenting with long term complication of diabetes such as severe retinopathy, severe renal involvement or with history of recurrent acute complications like hypoglycemia, ketoacidosis, polyneuropathy etc.
•xvi.Subjects with ill managed diabetes i.e. glycosylated hemoglobin (HbA1c) more than 8%
•xvii.Cases with other systemic diseases like cardiovascular, endocrinal diseases like thyroid dysfunction or Systemic infections or on other treatment therapies. (except for hypertensive and dyslipedemic patients on standard care)

发起方

Central Council for Research in Homoeopathy